Literature DB >> 28926830

A Distinctive Ictal Amplitude-Integrated Electroencephalography Pattern in Newborns with Neonatal Epilepsy Associated with KCNQ2 Mutations.

Ana Vilan1, José Mendes Ribeiro, Pasquale Striano, Sarah Weckhuysen, Lauren C Weeke, Eva Brilstra, Linda S de Vries, Maria Roberta Cilio.   

Abstract

BACKGROUND: Recurrent and prolonged seizures are harmful for the developing brain, emphasizing the importance of early seizure recognition and effective therapy. Amplitude-integrated electroencephalography (aEEG) has become a valuable tool to diagnose epileptic seizures, and, in parallel, genetic etiologies are increasingly being recognized, changing the paradigm of the workup and management of neonatal seizures.
OBJECTIVE: To report the ictal aEEG pattern in neonates with KCNQ2-related epilepsy. SUBJECTS AND METHODS: In this multicenter descriptive study, clinical data and aEEG findings of 9 newborns with KCNQ2 mutations are reported.
RESULTS: Refractory seizures occurred in the early neonatal period with similar seizure type, including tonic features, apnea, and desaturation. A distinct aEEG seizure pattern, consisting of a sudden rise of the lower and upper margin of the aEEG, followed by a marked depression of the aEEG amplitude, was found in 8 of the 9 patients. Prompt recognition of this pattern led to early treatment with carbamazepine in the 2 most recent cases.
CONCLUSION: Early recognition of the electroclinical phenotype by using aEEG may direct genetic testing and a precision medicine approach with sodium channel blockers in neonates with KCNQ2 mutations.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Amplitude-integrated electroencephalography; Carbamazepine; KCNQ2 mutations; KCNQ2-related epilepsy; Neonatal seizures

Mesh:

Substances:

Year:  2017        PMID: 28926830     DOI: 10.1159/000478651

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  8 in total

Review 1.  Neuromonitoring in Neonatal-Onset Epileptic Encephalopathies.

Authors:  Regina Trollmann
Journal:  Front Neurol       Date:  2021-02-02       Impact factor: 4.003

Review 2.  Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature.

Authors:  Raffaele Falsaperla; Bruna Scalia; Andrea Giugno; Piero Pavone; Milena Motta; Martina Caccamo; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2021-04-07       Impact factor: 2.638

3.  Early initial video-electro-encephalography combined with variant location predict prognosis of KCNQ2-related disorder.

Authors:  Yan Xu; Ya-Lan Dou; Xiang Chen; Xin-Ran Dong; Xin-Hua Wang; Bing-Bing Wu; Guo-Qiang Cheng; Yuan-Feng Zhou
Journal:  BMC Pediatr       Date:  2021-10-28       Impact factor: 2.125

4.  KCNQ2-Related Neonatal Epilepsy Treated With Vitamin B6: A Report of Two Cases and Literature Review.

Authors:  Greta Amore; Ambra Butera; Giulia Spoto; Giulia Valentini; Maria Concetta Saia; Vincenzo Salpietro; Francesco Calì; Gabriella Di Rosa; Antonio Gennaro Nicotera
Journal:  Front Neurol       Date:  2022-03-25       Impact factor: 4.003

5.  KCNQ2 Selectivity Filter Mutations Cause Kv7.2 M-Current Dysfunction and Configuration Changes Manifesting as Epileptic Encephalopathies and Autistic Spectrum Disorders.

Authors:  Inn-Chi Lee; Jiann-Jou Yang; Ying-Ming Liou; Swee-Hee Wong
Journal:  Cells       Date:  2022-03-05       Impact factor: 6.600

6.  Case Report: Effect of Targeted Therapy With Carbamazepine in KCNQ2 Neonatal Epilepsy.

Authors:  Robertino Dilena; Eleonora Mauri; Alessio Di Fonzo; Cristina Bana; Paola Francesca Ajmone; Claudia Rigamonti; Tamara Catenio; Silvana Gangi; Pasquale Striano; Monica Fumagalli
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

Review 7.  Precision Medicine in Neonates: A Tailored Approach to Neonatal Brain Injury.

Authors:  Maria Luisa Tataranno; Daniel C Vijlbrief; Jeroen Dudink; Manon J N L Benders
Journal:  Front Pediatr       Date:  2021-05-19       Impact factor: 3.418

Review 8.  Capturing seizures in clinical trials of antiseizure medications for KCNQ2-DEE.

Authors:  John J Millichap; Cynthia L Harden; Dennis J Dlugos; Jacqueline A French; Noam N Butterfield; Celene Grayson; Ernesto Aycardi; Simon N Pimstone
Journal:  Epilepsia Open       Date:  2021-01-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.